Gender features of myocardial structural and functional changes in patients with chronic glomerulonephritis at the predialysis stage of the disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Male patients with glomerulonephritis at the predialysis stage of chronic kidney disease show a predominance of concentric left ventricular hypertrophy that is associated with the development of clinically significant cardiac arrhythmias. Whereas female patients with chronic glomerulonephritis have a lower glomerular filtration rate, anemia, a higher frequency of eccentric left ventricular hypertrophy and supraventricular ectopic activity.

Full Text

Restricted Access

About the authors

I. Murkamilov

I.K. Akhunbaev Kyrgyz State Medical Academy; First President of Russia B.N. Yeltsin Kyrgyz-Russian Slavic University

Email: rzrmam@mail.ru
Candidate of Medical Sciences

K. Aitbaev

Research Institute of Molecular Biology and Medicine

Professor

V. Fomin

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Z. Rayimzhanov

Acad. N.N. Burdenko Main Military Clinical Hospital, Ministry of Defense of the Russian Federation

N. Redzhapova

Osh State University

F. Yusupov

Osh State University

Professor

Z. Aidarov

I.K. Akhunbaev Kyrgyz State Medical Academy

Professor

References

  1. Мухин Н.А. Нефрология. Национальное руководство. Краткое издание / М.: ГЭОТАР-Мед, 2016; с. 608.
  2. Brück K., Stel V., Gambaro G. et al. CKD prevalence varies across the European general population // J. Am. Soc. Nephrol. - 2016; 27 (7): 2135-47. D0I:10.1681/ASN.2015050542.
  3. Yuan J., Zou X., Han S. et al. and on behalf of the C-STRIDE study group. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the chinese cohort study of chronic kidney disease (C-STRIDE) // BMC Nephrol. - 2017; 18: 23. D0I:10.1186/s12882-017-0441-9.
  4. Моисеев В.С., Мухин Н.А., Смирнов А.В. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции // Рос. кардиол. журн. - 2014; 8: 7-37.
  5. Tong J., Liu M., Li H. et al. Mortality and Associated Risk Factors in Dialysis Patients with Cardiovascular Disease // Kidney Blood Press Res. - 2016; 41: 47987. D0I:10.1159/000443449.
  6. Hill N., Fatoba S., Oke J. et al. Global Prevalence of Chronic Kidney Disease-A Systematic Review and Meta-Analysis // PloS One. - 2016; 11 (7): e0158765. DOI: http://dx.doi.org/10.1371/journal.pone.0158765.
  7. Snaedal S., Axelsson J., Machowska A. et al. Markers of inflammation and cardiovascular disease in dialysis patients: variability and prognostic value / Stockholm: Karolinska University Hospital, 2016; 8: 1-10.
  8. Тареева И.Е. Нефрология. Руководство для врачей. 2-е изд., перераб. и доп. / М.: Медицина, 2000; 688.
  9. Levey A., Stevens L., Schmid C. et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate // Ann. Intern. Med. - 2009; 150 (9): 604-12. PMID: 19414839.
  10. ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Blood Press. - 2013; 22: 193-278. DOI: http://dx.doi.org/10.3109/08037051.2 013.812549
  11. Devereux R., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method // Circulation. - 1977; 55 (4): 613-8. PMID: 138494.
  12. Sato Y., Fujimoto S., Konta T. et al. Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease // Clin. Exp. Nephrol. -2017. doi: 10.1007/s10157-017-1468-8.
  13. Atkinson M., Warady B. Anemiainchronic kidney disease // Pediatr. Nephrol. - 2017. doi: 10.1007/s00467-017-3663-y.
  14. Муркамилов И.Т., Айтбаев К.А., Байсымакова Ф.К. и др. Факторы, способствующие прогрессированию гломерулонефритов и сердечно-сосудистых нарушений // Журнал здоровье и образование в XXI веке. - 2017; 19 (8): 32-9.
  15. Ryu S., Park S., Jung J. et al. The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) // J. Korean Med. Sci. - 2017; 32 (2): 249-56. DOI: https://doi.org/10.3346/jkms.2017.32.2.249.
  16. Eckardt K., Gillespie I., Kronenberg F. et al. ARO Steering Committee: High cardiovascular event rates occur within the first weeks of starting hemodialysis // Kidney Int. - 2015; 88: 1117-25. DOI: http://dx.doi.org/10.1038/ki.2015.117.
  17. Goldberg I., Krause I. The Role of Gender in Chronic Kidney Disease // EMJ. - 2016; 1 (2): 58-64.
  18. Locatelli F., Marcelli D., Conte F. et al. Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi eTrapianto // Nephrol. Dial. Transplant. - 2000; 15 (Suppl. 5): 69-80.
  19. Herzog C., Asinger R., Berger A. et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) // Kidney Int. - 2011; 80 (6): 572-86. doi: 10.1038/ki.2011.223.
  20. Волгина Г.В. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности // Нефрол. и диализ. - 2000; 2 (1-2): 25-32.
  21. Ali A., Macphee I., Kaski J. et al. Cardiac and vascular changes with kidney transplantation // Indian J. Nephrol. - 2016; 26 (1): 1-9. doi: 10.4103/0971 -4065.165003.
  22. McCullough P., Roberts W. Influence of chronic renal failure on cardiac structure // J Am. Coll. Cardiol. - 2016; 67 (10): 1183-5. DOI:10.1016/j. jacc.2015.11.065.
  23. Boriani G., Savelieva I., Dan G. et al. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society // EP Europace. - 2015; 17 (8): 1169-96. DOI: https://doi. org/10.1093/europace/euv202.
  24. Potpara T., Jokic V., Dagres N. et al. Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy // Curr. Med. Chem. - 2016; 23 (19): 2070-83. doi: 10.2174/0929867323 666160309114246.
  25. Alonso A., Lopez F., Matsushita K. et al. Chronic kidney diseaseis associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study // Circulation. - 2011; 123 (25): 2946-53. DOI: 10.1161/ CIRCULATIONAHA.111.020982.
  26. Santoro A., Mancini E., London G. et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal // Nephrol. Dial. Transplant. - 2008; 23 (4): 1415-21. DOI: https://doi. org/10.1093/ndt/gfm730.
  27. Дерюгин М.В., Бойцов С.А. Хронические миокардиты / СПб: ЭЛБИ-СПб, 2005; 288.
  28. Papademetriou V. Geometric patterns of left ventricular hypertrophy: Is geometry alone to be blamed? // Hellenic J. Cardiol. - 2017; 58 (2): 143-5. DOI: https://doi.org/10.1016/j.hjc.2017.05.010.
  29. Houghton J., Prisant L., Carr A. et al. Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease // Am. Heart J. - 1991; 121 (4): 1107-12.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies